Pharma’s AI Boom Has Bet on the Wrong Bottleneck
Michael A. Santoro is Professor of Management and Entrepreneurship at the Leavey School of Business, Santa Clara University. He is the author of Wall Street Values: Business Ethics and the Global Financial Crisis (Cambridge University Press) and has written widely on fiduciary duty, financial regulation, and corporate accountability. He is also co-editor of Ethics and the Pharmaceutical Industry (Cambridge University Press). His research focuses on business ethics, financial regulation, and the governance of markets and institutions, including the accountability of artificial intelligence systems. Santoro received a JD from the New York University School of Law and a PhD in Public Policy from Harvard University.
Related Stories
AI News
Nigerian startup FoodCourt suspends operations amid mounting debts
3 minutes ago
AI News
Quick Fashion Startup Klydo Shuts Shop, Teases Pivot
3 minutes ago
AI News
Aviation Technology Marks Landmark 25
4 minutes ago
AI News
‘It’s smoke and mirrors’: hope turns to fear in Scottish village chosen for AI datacentre
5 minutes ago
AI News
What are Britain’s AI growth zones and are the plans feasible or ‘complete bunk’?
5 minutes ago
AI News
Revealed: landmark Scottish AI project has no prospect of meeting renewables promise
5 minutes ago
AI News
Artificial Intelligence. Real War.
5 minutes ago
AI News
England's Henderson injures wrist in World Cup celebrations
56 minutes ago